Chardan Capital Lowers Passage Bio (NASDAQ:PASG) Price Target to $6.00
Passage Bio (NASDAQ:PASG – Get Free Report) had its target price lowered by Chardan Capital from $7.00 to $6.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Several other equities research analysts have also commented on the stock. Canaccord Genuity Group reissued a “buy” rating and […]
Passage Bio (NASDAQ:PASG – Get Free Report) had its target price lowered by Chardan Capital from $7.00 to $6.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Several other equities research analysts have also commented on the stock. Canaccord Genuity Group reissued a “buy” rating and […]
